Pharmacotherapy of bipolar II disorder: a critical review of current evidence.
- 1 February 2004
- journal article
- research article
- Published by Wiley in Bipolar Disorders
- Vol. 6 (1) , 14-25
- https://doi.org/10.1046/j.1399-5618.2003.00086.x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomaniaJournal of Affective Disorders, 2003
- Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000The Journal of Clinical Psychiatry, 2002
- Treatment Research in Bipolar DisorderCNS Drugs, 2002
- Role of risperidone in bipolar II: an open 6-month studyJournal of Affective Disorders, 2001
- Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case SeriesPharmacopsychiatry, 2001
- Bipolar II Disorder: Symptoms, Course, and Response to TreatmentPsychiatric Services, 2001
- A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar DisorderThe Journal of Clinical Psychiatry, 2000
- Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specifiedInternational Clinical Psychopharmacology, 1999
- Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?Journal of Affective Disorders, 1999
- Gabapentin Treatment of Mood DisordersThe Journal of Clinical Psychiatry, 1998